Hi, what are you looking for?
Former Speaker Nancy Pelosi, D-Calif, plans to skip President-elect Trump’s inauguration next week, her office told ABC News on Thursday. Pelosi has attended 11...
Trump’s transition team has reportedly asked three senior career diplomats to step down from their roles, according to Reuters. Dereck Hogan, Marcia Bernicat and...
President Biden is warning Americans of an ‘ultra-wealthy’ ‘oligarchy’ taking shape that is presenting a danger to the country, but did not mention in...
Lightning Minerals (L1M or the Company) is delighted to announce the discovery of spodumene within a lithium bearing pegmatite at the Company’s recently acquired...
Provaris Energy Ltd (ASX.PV1, Provaris, the Company) is pleased to present the notice of initial substantial holder. Click here for the full ASX Release...
India has successfully tested a domestically developed long-range hypersonic missile, it said on Sunday, attaining a key milestone in military development that puts it...
President-elect Trump announced on Sunday that he has picked Brendan Carr to serve as Chairman of the Federal Communications Commission (FCC) starting in January....
A new report revealed Vice President Kamala Harris’ presidential campaign paid more than double what was previously reported for the Oprah Winfrey town hall...
Ben Carson broke his silence around rumors of him joining the second Trump administration as the U.S. surgeon general on Sunday, but noted that...
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical and corporate updates highlighting the...
Perth, Australia (ABN Newswire) – BPH Energy Limited (ASX:BPH) provide a presentation by investee Cortical Dynamics at the Health Innovation Frontier Forum on 18th...
Ionic Rare Earths Limited (“IonicRE” or the “Company”) (ASX: IXR) wholly owned subsidiary Ionic Technologies is on track for the development of a unique...
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...